Merck & Co. Announced New Phase III Data for Suvorexant (MRK, XLS)
[ITT Exelis and Metron Aviation are collaborating to develop a joint product offering, Symphony® OpsVue with Harmony]
Online PR News – 10-September-2012 – Las Vegas, NV – Merck & Co. Inc. (NYSE:MRK) MRK, reported today new data for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. The new data are from one of the longest, continuously-dosed, placebo-controlled trials of a sleep medication ever conducted. This 12-month study was designed to assess the safety of suvorexant, while also evaluating its longer term efficacy. Merck presented new results from a two-month discontinuation phase that followed the 12-month study at the 21st Congress of the European Sleep Research Society (ESRS). Today's MRK is a global healthcare leader working to help the world be well. MRK is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com
ITT Exelis (NYSE:XLS) XLS and Metron Aviation are collaborating to develop a joint product offering, Symphony® OpsVue with Harmony. This product will provide airport and airline customers with a comprehensive view of their operations in the air and on the ground. Under the partnership, the product will incorporate the flexible flight data visualizations of Exelis Symphony® OpsVue with Metron Harmonys flow management and Collaborative Decision Making capabilities to track aircraft and vehicle movement gate-to-gate. XLS is a diversified, top-tier global aerospace, defense and information solutions company with strong positions in enduring and emerging global markets. XLS is a leader in networked communications, sensing and surveillance, electronic warfare, navigation, air traffic solutions and information systems with growing positions in cyber security, composite aerostructures, logistics and technical services. The company has a 50-year legacy of innovation and technology expertise, partnering with customers worldwide to deliver affordable, mission-critical products and services for managing global threats, conflicts and complexities. Headquartered in McLean, Va., the company employs about 20,500 people and generated 2011 sales of $5.8 billion. www.exelisinc.com
Crown Equity Holdings Inc. (CRWE) CRWE Tube, (www.crwetube.com) a video sharing site of CRWE, allows billions of people around the world to upload, watch and share original videos. With online videos continuing to experience explosive, viral growth and the web rapidly moving from text to video, businesses will need to adapt to the shift in video distribution technology or quickly become irrelevant to their consumers who anticipate seeing video everywhere online. CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. Crown Equity Holdings advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. For more information about Crown Equity Holdings Inc. visit www.crownequityholdings.com.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. (Read Full Disclaimer at http://pennytobuck.com/disclaimer).
Copyright 2015 Online PR Media | PO Box 5043 | La Quinta, CA 92248